Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Unexplained isolated hyperferritinemia without iron overload.

Ravasi G, Pelucchi S, Mariani R, Casati M, Greni F, Arosio C, Pelloni I, Majore S, Santambrogio P, Levi S, Piperno A.

Am J Hematol. 2017 Apr;92(4):338-343. doi: 10.1002/ajh.24641. Epub 2017 Feb 7.

2.

Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment.

Poli L, Alberici A, Buzzi P, Marchina E, Lanari A, Arosio C, Ciccone A, Semeraro F, Gasparotti R, Padovani A, Borroni B.

Neurol Sci. 2017 Feb;38(2):357-360. doi: 10.1007/s10072-016-2756-x. Epub 2016 Nov 5.

PMID:
27817091
3.

Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?

Pelucchi S, Pelloni I, Arosio C, Mariani R, Piperno A.

Blood Cells Mol Dis. 2016 Mar;57:112-4. doi: 10.1016/j.bcmd.2015.12.011. Epub 2015 Dec 30. No abstract available.

PMID:
26777753
4.

Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype.

Ravasi G, Rausa M, Pelucchi S, Arosio C, Greni F, Mariani R, Pelloni I, Silvestri L, Pineda P, Camaschella C, Piperno A.

Am J Hematol. 2015 Dec;90(12):E226-7. doi: 10.1002/ajh.24202. Epub 2015 Nov 17. No abstract available.

5.

Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.

Melgari JM, Marano M, Quattrocchi CC, Piperno A, Arosio C, Frontali M, Nuovo S, Siotto M, Salomone G, Altavilla R, di Biase L, Scrascia F, Squitti R, Vernieri F.

Parkinsonism Relat Disord. 2015 Jun;21(6):658-60. doi: 10.1016/j.parkreldis.2015.03.014. Epub 2015 Mar 19. No abstract available.

PMID:
25864092
6.

An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma.

Mainini V, Pagni F, Garancini M, Giardini V, De Sio G, Cusi C, Arosio C, Roversi G, Chinello C, Caria P, Vanni R, Magni F.

Endocr Pathol. 2013 Dec;24(4):250-3. doi: 10.1007/s12022-013-9273-8. No abstract available.

PMID:
24142502
7.

Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes.

Mariani R, Pelucchi S, Arosio C, Coletti S, Pozzi M, Paolini V, Trombini P, Piperno A.

Blood Cells Mol Dis. 2010 Mar 15;44(3):159-63. doi: 10.1016/j.bcmd.2010.01.002. Epub 2010 Feb 8.

PMID:
20117027
8.

Higher than expected progranulin mutation rate in a case series of Italian FTLD patients.

Tremolizzo L, Gelosa G, Galbussera A, Isella V, Arosio C, Bertola F, Casati G, Piperno A, Ferrarese C, Appollonio I.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):301. doi: 10.1097/WAD.0b013e31819e0cc5. No abstract available.

PMID:
19730171
9.

Homozygous deletion of HFE: the Sardinian hemochromatosis?

Pelucchi S, Mariani R, Bertola F, Arosio C, Piperno A.

Blood. 2009 Apr 16;113(16):3886. doi: 10.1182/blood-2008-12-196493. No abstract available.

10.

Novel human pathological mutations. Gene symbol: ALPL. Disease: hypophosphatasia.

Bertola F, Arosio C, Casati G, Piperno A, Crosti F, Colombo C.

Hum Genet. 2009 Apr;125(3):334. No abstract available.

PMID:
19309795
11.

Chemical and physical properties of sulfated silk fabrics.

Taddei P, Arosio C, Monti P, Tsukada M, Arai T, Freddi G.

Biomacromolecules. 2007 Apr;8(4):1200-8. Epub 2007 Mar 6.

PMID:
17338562
12.

Tyrosinase-catalyzed grafting of sericin peptides onto chitosan and production of protein-polysaccharide bioconjugates.

Anghileri A, Lantto R, Kruus K, Arosio C, Freddi G.

J Biotechnol. 2007 Jan 10;127(3):508-19. Epub 2006 Jul 29.

PMID:
16934898
13.

Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.

Corengia C, Galimberti S, Bovo G, Vergani A, Arosio C, Mariani R, Redaelli A, Riva A, Cestari C, Pozzi M, Valsecchi MG, Piperno A.

Am J Clin Pathol. 2005 Dec;124(6):846-53.

PMID:
16416733
14.

Wet spinning of Bombyx mori silk fibroin dissolved in N-methyl morpholine N-oxide and properties of regenerated fibres.

Marsano E, Corsini P, Arosio C, Boschi A, Mormino M, Freddi G.

Int J Biol Macromol. 2005 Dec 15;37(4):179-88. Epub 2005 Nov 21.

PMID:
16303174
15.

Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.

Mariani R, Arosio C, Pelucchi S, Grisoli M, Piga A, Trombini P, Piperno A.

Gut. 2004 May;53(5):756-8.

16.

Type 3 hemochromatosis and beta-thalassemia trait.

Riva A, Mariani R, Bovo G, Pelucchi S, Arosio C, Salvioni A, Vergani A, Piperno A.

Eur J Haematol. 2004 May;72(5):370-4.

PMID:
15059075
17.

Prevalence of HFE mutations in upper Northern Italy: study of 1132 unrelated blood donors.

Mariani R, Salvioni A, Corengia C, Erba N, Lanzafame C, De Micheli V, Baldini V, Arosio C, Fossati L, Trombini P, Oberkanins C, Piperno A.

Dig Liver Dis. 2003 Jul;35(7):479-81.

PMID:
12870733
18.

Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry.

Salvioni A, Mariani R, Oberkanins C, Moritz A, Mauri V, Pelucchi S, Riva A, Arosio C, Cerutti P, Piperno A.

Haematologica. 2003 Mar;88(3):250-5.

19.

Epidemiology of Chlamydia pneumoniae.

Blasi F, Tarsia P, Arosio C, Fagetti L, Allegra L.

Clin Microbiol Infect. 1998 Jan;4 Suppl 4:S1-S6.

20.

Systemic inflammatory response after bronchoalveolar lavage in critically ill patients.

Bauer TT, Arosio C, Montón C, Filella X, Xaubet A, Torres A.

Eur Respir J. 2001 Feb;17(2):274-80.

Supplemental Content

Loading ...
Support Center